Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2306800 | 0.80 | TUBB1 (0.31) | ACHE | |
| SCHEMBL744322 | 0.80 | ACHE (0.44) | ACHECYP3A4MAPTCA9MEN1 | |
| SCHEMBL9444241 | 0.77 | CYP3A4 (0.40) | ACHECYP3A4MAPTCA9MEN1 | |
| SCHEMBL2828160 | 0.77 | GAA (0.32) | ACHECYP3A4MAPTCA9 | |
| SCHEMBL2304755 | 0.74 | ALDH1A1 (0.36) | CYP3A4PTGS2 | |
| SCHEMBL2862955 | 0.72 | KDM4E (0.37) | CYP3A4MAPTKMT2A | |
| SCHEMBL7679493 | 0.71 | ACHE (0.34) | ACHE | |
| SCHEMBL28136118 | 0.71 | PDE4B (0.42) | CYP3A4MAPTCA9 | |
| SCHEMBL16071623 | 0.70 | ACHE (0.52) | ACHECYP3A4MAPTCA9MEN1 | |
| SCHEMBL28412483 | 0.70 | PKM (0.43) | CYP3A4MAPTMEN1KMT2APTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023190912-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 日本ポリケム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3978537-B1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | UNIV TOKYO (JP) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023033030-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 国立大学法人 東京大学 | 2023-03-09 | — | — | WO | disclosed |
| US-20220220239-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | THE UNIVERSITY OF TOKYO (JP) | 2022-07-14 | — | — | US | disclosed |
| CN-113874402-A | Polar group-containing olefin copolymer | 国立大学法人东京大学 | 2021-12-31 | — | — | CN | disclosed |
| US-20160237184-A1 | IMINE COMPOUND, NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER | JAPAN POLYPROPYLENE CORPORATION (JP) | 2016-08-18 | — | — | US | disclosed |
| EP-3050892-A1 | IMINE COMPOUND AND NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | Japan Polypropylene Corporation (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2351761-B1 | NOVEL METAL COMPLEX, AND METHOD FOR PRODUCING -OLEFIN POLYMER AND METHOD FOR PRODUCING -OLEFIN/(METH)ACRYLATE COPOLYMER EACH USING THE METAL COMPLEX | JAPAN POLYPROPYLENE CORP (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2351761-A1 | NOVEL METAL COMPLEX, AND METHOD FOR PRODUCING -OLEFIN POLYMER AND METHOD FOR PRODUCING -OLEFIN/(METH)ACRYLATE COPOLYMER EACH USING THE METAL COMPLEX | Japan Polypropylene Corporation (JP) | 2011-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237184-A1 | IMINE COMPOUND, NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER | ODC1, MACF1, MOGAT2 | ACHE 3805/4885CYP3A4 122/4885MAPT 1293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.